The DxH 900 Hematology Analyzer delivers accurate, first-analysis results through proprietary VCS technology
The analyzer is compatible with clinical informatics and automation solutions to form scalable, customized solutions
Deliver reliable, reportable WBC differential results on the first run, through VCS technology, DataFusion and the enhanced Coulter Principle
The enhanced Coulter Principle provides a reportable MPV - even for thrombocytopenic patients - while DataFusion leverages inter-module intelligence to enable improved flagging and identification of interferences
Assess anemia with accuracy by maintaining near native-state cellular characterization throughout the RBC maturation cycle
Utilize a new reportable parameter for the emergency department to identify the possibility of infection earlier to stop potentially deadly complications from developing or progressing, helping to reduce the cost of care
Streamline QA/QC processes through customizable, automated technology with daily reminders and remote support
Maximize efficiency with one-touch sample processing with total laboratory automation and clinical information management tools
Optimize operations through a seamless workflow, small footprint, intuitive software and easy maintenance
Exclusive to the DxH 900 and 690T analyzers is the regulatory-cleared hematological biomarker Monocyte Distribution Width (MDW) that aids physicians in identifying severity of infection and risk of sepsis in adult Emergency Department patients; this marker is available early in patient assessment as part of a CBC-Diff test with no impact to workflow
